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A Genome-Wide Association Study Identiﬁes
the Skin Color Genes IRF4, MC1R, ASIP, and
BNC2 Inﬂuencing Facial Pigmented Spots
Leonie C. Jacobs1,2, Merel A. Hamer1,2, David A. Gunn3, Joris Deelen2,4, Jaspal S. Lall3, Diana van Heemst5,
Hae-Won Uh6, Albert Hofman7, André G. Uitterlinden2,7,8, Christopher E.M. Grifﬁths9, Marian Beekman2,4,
P. Eline Slagboom2,4, Manfred Kayser10, Fan Liu10 and Tamar Nijsten1,2
Facial pigmented spots are a common skin aging feature, but genetic predisposition has yet to be thoroughly
investigated. We conducted a genome-wide association study for pigmented spots in 2,844 Dutch Europeans
from the Rotterdam Study (mean age: 66.9± 8.0 years; 47% male). Using semi-automated image analysis of high-
resolution digital facial photographs, facial pigmented spots were quantiﬁed as the percentage of affected skin
area (mean women: 2.0% ± 0.9, men: 0.9% ± 0.6). We identiﬁed genome-wide signiﬁcant association with
pigmented spots at three genetic loci: IRF4 (rs12203592, P= 1.8× 10− 27), MC1R (compound heterozygosity score,
P= 2.3× 10− 24), and RALY/ASIP (rs6059655, P= 1.9× 10− 9). In addition, after adjustment for the other three top-
associated loci the BNC2 locus demonstrated signiﬁcant association (rs62543565, P= 2.3× 10− 8). The association
signals observed at all four loci were successfully replicated (Po0.05) in an independent Dutch cohort (Leiden
Longevity Study n= 599). Although the four genes have previously been associated with skin color variation and
skin cancer risk, all association signals remained highly signiﬁcant (Po2× 10− 8) when conditioning the
association analyses on skin color. We conclude that genetic variations in IRF4, MC1R, RALY/ASIP, and BNC2
contribute to the acquired amount of facial pigmented spots during aging, through pathways independent of the
basal melanin production.
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INTRODUCTION
Facial pigmented spots are regarded as a common skin aging
feature (Ortonne, 1990). In global populations, the demand
for products that prevent the appearance of skin aging features
has increased markedly. However, to offer substantiated
advice and effective treatment, it is prerequisite to understand
skin aging etiology.
Pigmented spots (solar lentigines and seborrheic keratosis)
are part of the complex skin aging phenotype, which also
includes wrinkling, sagging, and telangiectasia, which
together are considered as one skin aging phenotype in
previous studies (Guinot et al., 2002; Vierkotter et al., 2009).
Important known risk factors for skin aging include age,
cumulative UV exposure, and light skin color (Bastiaens et al.,
2004; Monestier et al., 2006; Ezzedine et al., 2012). Candi-
date gene studies have been performed, where gene variants
in the pigmentation genes SLC45A2 in Asians (Vierkotter
et al., 2012) and MC1R (melanocortin 1 receptor) in
Europeans (Bastiaens et al., 2001a) have been found to be
associated with the presence of solar lentigines. However, the
genetic predisposition to facial pigmented spots has not been
investigated at the genome-wide scale.
To provide insight into which other genes may be involved
in the development of pigmented spots during aging, we
performed a genome-wide association study (GWAS) in 2,844
individuals of Dutch ancestry from the Rotterdam Study (RS).
Facial pigmented spots were quantiﬁed from high-resolution
digital photographs, using semi-automated image analysis.
We then replicated our ﬁndings in an independent cohort of
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599 Dutch participants of the Leiden Longevity Study (LLS).
To clarify whether the genetic associations with pigmented
spots were independent of skin color or not, we additionally
adjusted the identiﬁed associations for skin color.
RESULTS
Discovery GWAS
All 2,844 individuals from the discovery RS cohort (mean age:
66.9± 8.0 years, 47% men, Table 1) were of North-European
ancestry. Women were more severely affected with on
average 2.0% (±0.9%) of their facial area being covered by
pigmented spots (Figure 1), compared with men (0.9%
(±0.6%, Table 1)). A total of 167 single-nucleotide poly-
morphism (SNPs; nine genotyped SNPs, Supplementary
Table S1 online) in three distinct loci showed genome-wide
signiﬁcant association with pigmented spots (Po5× 10−8,
Figure 2, Supplementary Figure S1 online). All three loci
harbor a known skin color gene, namely IRF4 (6p25), MC1R
(16q24), and ASIP (20q11). The most strongly associated SNP
was rs12203592(T) in the 4th intron of IRF4 (24.9%Δ per
allele, P= 1.9× 10− 27, Table 2, Supplementary Figure S2A
online). The association at 16q24 consisted of a large number
of SNPs (Supplementary Figure S2B online). This locus
contains many genes, and the top-associating SNP was
rs35063026(T) (20.29%Δ, P= 9.4× 10− 15) located in exon
3 of c16orf55/SPATA33, which is ~ 250 kb upstream from the
skin color gene MC1R. The third locus was found at 20q11,
where the most strongly associated SNP rs6059655(A) was
located in intron 8 of the RALY gene (14.6%Δ, P=2.6× 10−9,
Table 2, Supplementary Figure S2C online). RALY is located
o200 kb upstream from the skin color gene ASIP. Linkage
disequilibrium between the top-associated SNP in ASIP
(rs1205312(A) P= 1.8× 10− 6) and rs6059655 was substantial
(r2=0.59).
We performed a second genome-wide association analysis
for pigmented spots in the RS, conditional on the three most
strongly associating SNPs (rs12203592 (IRF4), rs35063026
(MC1R), and rs6059655 (RALY/ASIP)). In this conditional
analysis, none of the SNPs at the IRF4 and RALY loci were
associated with pigmented spots at genome-wide signiﬁcance
(P40.005). In contrast, at the MC1R locus, a large number
(n=31) of SNPs still showed genome-wide signiﬁcant
association. Interestingly, one additional locus at 9p22 was
identiﬁed to be signiﬁcantly associated with pigmented spots,
where rs62543565(C) showed the most signiﬁcant association
(−6.4%Δ, P=2.3×10−8). This SNP is located 30 kb upstream
from Basonuclin 2 (BNC2; Supplementary Figure S2D online),
which was recently found to be involved in skin coloration
(Jacobs et al., 2013). A sex-stratiﬁed GWAS could not identify
new loci or SNPs with strong sex-speciﬁc effects (Supple-
mentary Table S2 online).
Replication of ﬁndings
A replication study for the 168 top-associated SNPs was
conducted in an independent cohort, the LLS, also of Dutch
ancestry (Supplementary Table S1 online). This study con-
sisted of 599 individuals (mean age: 63.1± 6.7 years, 46%
men), with facial pigmented spots graded in severity
categories (ranging from 2 to 8, mean: 4.4± 1.2). Although
the pigmented spot phenotype of this replication cohort was
assessed differently (categorical) compared with the discovery
cohort (percentage of affected area), both methods reﬂect
the severity of facial pigmented spots. The four top SNPs
from the discovery GWAS were all successfully replicated in
the LLS (Po0.05, Table 2). These included rs12203592(T)
Table 1. Characteristics of 2,844 Dutch participants
from the Rotterdam Study
Characteristics Men (n= 1,521) Women (n=1,323)
Pigmented spots; mean (SD) 0.9% (0.6) 2.0% (0.9)
Age (years); mean (SD) 67.1 (7.9) 66.8 (8.0)
Skin color; number (%) 1,521 1,323
Very white 100 (7.6) 142 (9.3)
White 1,016 (76.8) 1,199 (78.6)
White-to-olive 207 (15.6) 184 (12.1)
Pigmented spots were measured as affected area per total-measured
facial area.
Figure 1. Example image of pigmented spot detection. (a) All non-skin areas were masked. The arrows are pointing at pigmented spots. (b) This contrasted image
targets features approximate in size to pigmented spots, which appear blue to white in color (brown to black in the regular photograph). (c) Spots subsequently
detected as pigmented spots are shaded.
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(IRF4, beta: 0.44, P= 4.4× 10−4), rs35063026(T) (MC1R,
beta=0.08, P= 0.011), rs6059655(A) (RALY/ASIP, beta=
0.10, P= 0.009), and rs62543565(C) (BNC2 (non-conditional
analysis), beta=− 0.15, P= 0.033).
MC1R compound heterozygosity
The association pattern at chr16q24 was consistent
with previous GWAS ﬁndings of skin color (Sulem et al.,
2007; Han et al., 2008; Sulem et al., 2008), where multiple
SNPs in a large region around MC1R demonstrate
independent association (Supplementary Figure S2B online).
There are six SNPs within MC1R that are frequent in
Europeans (MAF41%) and associate with skin color together
in a compound heterozygous manner (Liu et al., 2011).
Compound heterozygosity implies that if both homo-
logous chromosomes carry one effect allele but in different
SNPs, the effect is similar to that of a homozygous allele. In
the RS, a compound heterozygosity score (CHS) was
calculated from the haplotypes of the six independent skin
color-associated MC1R SNPs (Supplementary Table S3
online). The CHS was more significantly associated
with pigmented spots (%Δ14.0, P= 1.6× 10−24) than the
top-associated SNP in this region, demonstrating that com-
pound heterozygosity also has a role in pigmented spot
development. In addition, when the GWAS was adjusted for
the CHS, no more genome-wide signiﬁcant SNPs on
chr16q24 could be detected; this implies that these six
MC1R skin color SNPs together explained a large part of the
MC1R association with pigmented spots.
Skin color-adjusted analyses
Because all four identiﬁed loci are known to be involved
in skin color, we performed additional skin color-adjusted
and -stratiﬁed analyses in the RS. Adjustment for skin color
showed that IRF4 and BNC2 SNPs hardly reduced in
association effect size. MC1R (CHS) and RALY/ASIP
(rs6059655) slightly reduced in effect size (~8.5% lower %Δ)
but were still genome-wide signiﬁcant (Table 3).
Stratiﬁcation for the three skin color categories showed that
the effect sizes (%Δ) in the very white and the white skin color
subgroups were similar for all four top SNPs (Table 3). The
SNPs in RALY/ASIP (rs6059655) and BNC2 (rs62543565) did
not reach signiﬁcance in the very white subgroup, likely
because of the small sample size (n=241). The effect sizes
were stronger in the white-to-olive skin color subgroup,
although only rs12203592 (IRF4) showed a signiﬁcant
interaction with skin color (P= 0.04).
In addition, we investigated whether other well-known
pigmentation genes associated with pigmented spots, which
we might not have picked up with the GWAS, due to
smaller effect sizes (Table 4). However, none of the eight
additional pigmentation genes we selected showed signiﬁcant
association with pigmented spots (Po0.005). The total
variance of the pigmented spot phenotype explained by
age, sex, skin color, and the pigmentation genes combined
was very high (r2=40.3%, Table 4), with sex (r2= 30.4%) and
age (r2= 3.5%) being the strongest predictors. The IRF4 SNP
rs12203592 explained the largest proportion of the pheno-
typic variance (r2= 2.3%) of the four top SNPs combined
(r2=5.6%).
The four genes that associated with pigmented spots risk
here also showed association with perceived skin color
in a previous investigation in the RS (Jacobs et al., 2013).
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Figure 2. Manhattan plot of the GWAS in 2844 Dutch individuals from the
Rotterdam Study. The observed − log10 P-values (y-axis) of the association
between each single-nucleotide polymorphism (SNP) and pigmented spots
are shown. All SNPs are represented by dots and displayed per chromosome
(x-axis). The horizontal line indicates the genome-wide signiﬁcant threshold
of P=5× 10−8. Genotyped SNPs passing this threshold are colored black.
Table 2. GWAS in the discovery cohort and the replication results, for pigmented spots in two independent Dutch
cohorts
Discovery cohort
RS (n= 2,844)
Replication cohort
LLS (n= 599)
Chromosome Gene SNP EA EAF %Δ SE P-value EAF Beta SE P-value
6p25 IRF4 rs12203592 T 0.09 24.94 2.05 1.9×10−27 0.08 0.44 0.12 4.4×10−4
9p22 BNC2 rs62543565 C 0.37 −6.32 1.25 1.5× 10−7 0.41 −0.15 0.07 0.033
16q24 MC1R rs35063026 T 0.07 20.29 2.40 9.4×10−15 0.08 0.33 0.13 0.011
20q11 RALY/ASIP rs6059655 A 0.08 14.58 2.31 2.6× 10−9 0.10 0.30 0.11 0.009
Abbreviations: EA, effect allele, or minor allele; EAF, effect allele frequency; GWAS, genome-wide association study; LLS, Leiden Longevity Study;
RS, Rotterdam Study; SE, standard error of the %Δ/beta; SNP, single-nucleotide polymorphism.
The most signiﬁcant signal per locus of the GWAS in the RS with a P-valueo5× 10−7 is shown. The signals were replicated in the LLS. Beta is the increase in
pigmented spots severity category, per increase in effect allele.
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The most striking difference between the association with
skin color and pigmented spots, in terms of signiﬁcance,
was observed for HERC2, where rs12913832 showed
a highly signiﬁcant association with skin color (P=1.5×
10−109 (Jacobs et al., 2013)), but not with pigmented spots
(P= 0.49, Table 4).
DISCUSSION
We detected SNPs in and around the genes IRF4, MC1R,
ASIP, and BNC2 that demonstrated genome-wide signiﬁcant
associations with facial pigmented spots, and all were
successfully replicated in a second independent cohort.
Furthermore, our data demonstrate that the associations of
IRF4, MC1R, ASIP, and BNC2 with facial pigmented spots
were at least partially independent of skin color.
The four identiﬁed genes are known to be associated with
visible skin traits in Europeans, including pigmentation
variation (eye, hair, and skin color; Sulem et al., 2007; Han
et al., 2008; Jacobs et al., 2013), freckling (Sulem et al., 2007;
Eriksson et al., 2010), tanning response (Nan et al., 2009), and
different types of skin cancer (basal cell carcinoma, squamous
cell carcinoma, and melanoma; Bishop et al., 2009; Stacey
et al., 2009; Nan et al., 2011; Zhang et al., 2013). However,
not all skin color-associated genes have an additional effect
on the development of pigmented spots, such as HERC2.
Previously, GWAS on skin sagging and global photoaging did
Table 3. Skin color-adjusted and -stratiﬁed analysis in 2,844 Dutch individuals from the RS
Analysis n
IRF4
rs12203592
MC1R
CHS
RALY/ASIP
rs6059655
BNC2
rs62543565
%Δ P-value %Δ P-value %Δ P-value %Δ P-value
SC adjusted 2,844 24.12 2.3× 10−26 12.85 3.5× 10−21 13.32 3.7×10− 8 − 6.20 2.0×10−7
SC stratiﬁed
Very white 241 21.85 2.8× 10−5 11.88 2.9×10− 3 8.91 0.179 − 5.43 0.141
White 2,212 21.54 4.5× 10−17 11.70 3.7× 10−15 13.25 7.7×10− 7 − 5.38 6.7×10−5
White-to-olive 391 46.37 6.3× 10−10 19.80 9.5×10− 7 19.10 0.028 − 12.09 3.1×10−4
Abbreviations: %Δ, percentage change in the pigmented spots area, per increase in effect allele; CHS, compound heterozygosity score; RS, Rotterdam Study;
SC, skin color; SC adjusted, regression analysis additionally adjusted for skin color; SC stratiﬁed, regression analysis per skin color stratum.
Table 4. Multivariable analysis of pigmentation genes and pigmented spots in 2,844 Dutch individuals from the RS
Factor SNP EA EAF %Δ SE P-value r2 (%)
Age (years) 1.50 0.11 1.1× 10−42 3.54
Female sex 86.91 1.69 1.0× 10−245 30.39
Light skin color −9.39 1.87 1.2× 10−7 0.57
SLC45A2 rs16891982 C 0.03 −6.83 3.78 0.056 0.06
IRF4 rs12203592 T 0.09 24.43 2.03 5.4× 10−27 2.26
TYRP1 rs1408799 T 0.31 1.74 1.28 0.175 0.03
BNC2 rs62543565 C 0.37 −6.54 1.21 2.3× 10−8 0.58
TPCN2 rs35264875 T 0.17 −1.58 1.57 0.308 0.02
TYR rs1393350 A 0.23 2.71 1.41 0.057 0.06
KITLG rs12821256 C 0.13 0.83 1.76 0.637 0.004
SLC24A4 rs12896399 G 0.49 −0.15 1.19 0.900 0.0003
OCA2 rs1800407 T 0.05 −4.50 3.04 0.125 0.04
HERC2 rs12913832 A 0.22 1.07 1.57 0.494 0.01
MC1R CHS — — 13.42 1.27 6.6× 10−23 2.02
RALY/ASIP rs6059655 A 0.08 13.45 2.26 1.9× 10−8 0.74
Total 40.32
Abbreviations: %Δ, percentage change in the pigmented spots area, per increase in effect allele; EA, effect allele; EAF, effect allele frequency;
r2 = percentage variance in pigmented spots area, explained by the predictor; RS, Rotterdam Study; SNP, single-nucleotide polymorphism.
Multivariable linear regression analysis. Age, sex, skin color, the four top SNPs from the GWAS, and the top SNPs of eight known pigmentation genes were
tested. For MC1R, the CHS was used (compound heterozygosity score).
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not identify any skin color genes being involved (Le Clerc
et al., 2013; Jacobs et al., 2014), but we now demonstrate that
skin color genes clearly have a role in the appearance of a
speciﬁc feature of skin aging.
The SNP rs12203592 in IRF4 (IFN regulatory factor 4)
showed the strongest association with pigmented spots,
explaining more than two percent of the phenotypic variance.
Gene variants in IRF4 are also associated with related
phenotypes, namely skin color, freckling, and all skin cancer
types (Han et al., 2008; Eriksson et al., 2010; Han et al.,
2011). Similarly, the compound MC1R haplotype was
strongly associated with pigmented spots, explaining two
percent of the variation. Many SNPs located close to MC1R
showed association and, after adjusting for the MC1R CHS,
no more SNPs were genome-wide signiﬁcantly associated. All
common variants in MC1R are associated with hair and skin
color, freckling, and all skin cancer types (Han et al., 2006,
2008; Sulem et al., 2008; DiGiovanna and Kraemer, 2012),
showing that MC1R is pleiotropic in nature. The rs6059655
SNP in RALY (heterogeneous nuclear ribonucleoprotein) is
located close to the skin color gene ASIP (agouti signaling
protein). In previous studies, many variants around ASIP
showed association with skin color-related phenotypes such
as freckling and sun sensitivity and skin cancer (Brown et al.,
2008; Sulem et al., 2008). Hence, the RALY SNP could affect
ASIP expression via a long-range regulation, or it is in LD with
another SNP closer to ASIP, which is affecting the ASIP
expression (Liu et al., 2013). Finally, rs62543565 close to
BNC2 was genome-wide signiﬁcantly associated with pig-
mented spots after adjusting for the other three top-associated
SNPs. Variants in BNC2 are associated with skin color (Jacobs
et al., 2013), and with freckling (Eriksson et al., 2010), but not
yet found to be associated with skin cancer. This is a relatively
new skin color gene, and the function of BNC2 in
pigmentation needs to be further investigated in future
studies. The four pigmentation genes together explain a
non-trivial portion of 5.6% of the phenotypic variance, which
is large compared with typical human complex traits––e.g.,
for adult body height ~ 2,000 SNPs together could explain
about 21% phenotypic variance (Wood et al., 2014).
The gene variant associations with pigmented spots were
found to be independent of skin color, similar to what is found
for gene variants that are associated with different types of
skin cancer (Bastiaens et al., 2001b; Han et al., 2006;
Kosiniak-Kamysz et al., 2012). Pigmented spots and skin
cancer share cumulative UV exposure as a major risk factor,
and facial pigmented spots have also shown to be a risk factor
for skin cancer (Dubin et al., 1990; Kricker et al., 1991). In
addition, in the rare recessively inherited disease xeroderma
pigmentosum, all affected individuals suffer from many solar
lentigines and skin (pre-) malignancies from a young age
onward because of a defect in DNA-repair mechanisms
(DiGiovanna and Kraemer, 2012). Therefore, it could be
hypothesized that a less effective repair of UV-induced DNA
damage explains the skin color independent effects of skin
color genes in pigmented spots and skin cancer. In support of
this, MC1R loss of function alleles have been associated with
a higher level of UV-induced DNA damage in melanocytes
(April and Barsh, 2007; Wong et al., 2012), which is
independent of the total melanin content (Hauser et al.,
2006). Possibly, the melanocytes react to DNA damage by
locally boosting melanin production to provide a subsequent
UV protection. However, the speciﬁc role of these genes in
the development of pigmented spots histology remains
elusive.
DNA variants at all four loci, in particular IRF4, showed a
stronger effect in dark colored individuals compared with
white skinned individuals in a skin color-stratiﬁed analysis.
Such an effect has been shown before for MC1R and
melanoma (Pasquali et al., 2014). Possibly, individuals with
a darker skin color are less likely to avoid the sun as they will
burn less easily, which aggravates the effect by cumulative
UV exposure. A second hypothesis is that the gene variant
effects in the lighter skin color groups are ameliorated by
other gene variants prevalent in these groups. This is
supported by the observation that light skin color is still
signiﬁcantly associated with pigmented spots after adjustment
for the top SNPs found here.
In women, we found a much higher prevalence of facial
pigmented spots with 30% of the pigmented spot variance
explained by sex, which could not be explained by genetic
differences in our study. Previous studies are inconclusive
about sex differences; some found a higher risk in women
(Bastiaens et al., 2004) and others in men (Suppa et al., 2011).
Although we cannot rule out that our computer-aided
phenotyping method used here was biased for pigmented
spot detection in female compared with male skin, the same
sex difference was also present in the LLS expert grading data,
which were manually graded by experts (Gunn et al., 2013).
Possible explanations are that higher levels of estrogen and
progesterone may increase the risk of developing pigmented
spots (Ezzedine et al., 2012), women may exhibit a different
life style, or epigenetic regulation mechanisms may differ
among the sexes.
To our knowledge, digitally quantiﬁed pigmented spots to
identify risk factors are previously unreported. Photonumeric
scales have been used to asses pigmented spot severity
(Chung et al., 2001; Suppa et al., 2011), but the advantage of
digital quantiﬁcation is a more objective and a more sensitive
approach. However, a possible disadvantage is the inability to
differentiate between the different facial pigmented lesions.
We aimed to measure solar lentigines as a skin aging
characteristic but simultaneously measured seborrheic
keratosis (brown warty lesions in elderly). It is unlikely that
other types of pigmented facial spots (melanocytic nevi,
freckles, and melasma (Maize and Foster, 1979; Castanet and
Ortonne, 1997; Ezzedine et al., 2012)) have biased our
measure because they are more common in young
individuals, and we additionally excluded all heavily
freckled individuals. Therefore, our pigmented spot
phenotype consists of solar lentigines and (a minority of)
seborrheic keratosis. Because these two are often assumed to
reﬂect the same phenotype (histologically they show clear
overlapping features (Ackerman and Ragaz, 1984)), the
elucidated genes likely inﬂuence both, but this should be
conﬁrmed in future research.
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CONCLUSION
DNA variants in IRF4, MC1R, ASIP, and BNC2 are signif-
icantly associated with facial pigmented spots indepen-
dently of age, sex, and skin color. Future studies should
investigate the biological function of these genes in the skin
and, in particular, how they could be inﬂuencing pigmented
spot development independently of basal melanin
production.
MATERIALS AND METHODS
Study populations
RS. The RS is a population-based prospective study of unrelated
elderly subjects (445 years of age) consisting of an initial cohort and
two extensions (Hofman et al., 2013). The present study includes
2,844 participants of north-western European ancestry, for whom
facial photographs and genotype data were available, after quality
control. During routine visits at the research center, a full-body
skin examination was performed by trained physicians and high-
resolution standardized full-face photographs were obtained of
participants not wearing make-up, creams, or jewelry, using a
premier 3dMD face3-plus UHD (3dMD, Atlanta, Georgia). The
photos used in this study were collected from September 2010 to
July 2013. The medical ethics committee of the Erasmus MC
University Medical Center approved the study protocol, and all
participants provided written informed consent.
LLS. The LLS has been described in detail previously (Schoenmaker
et al., 2006). This family-based study consists of 1,671 offspring of
421 nonagenarian sibling pairs of Dutch descent and their 744
partners. The current study includes 599 participants with facial
pigmented spot grades and genotype data available after quality
control. During routine visits at the Leiden research center,
high-resolution standardized full-face photographs were obtained
of participants not wearing make-up, creams, or jewelry, using
a Fuji S2 (Tokyo, Japan) camera system. The photos used in this
study were collected from November 2006 to April 2008. The study
protocol was approved by the medical ethics committee of the
Leiden University Medical Center, and all participants gave written
informed consent.
Phenotyping
In the RS, pigmented spot presence was digitally quantiﬁed using
semi-automated image analysis of high-resolution facial frontal
photographs. The algorithms, digital rendering, measurement, and
validation of the outcome measure have been described in detail
using a randomly selected subset of images of 100 participants
(Hamer et al., 2014). In short, the analysis detects areas that are dark
brown, i.e., hyperpigmented relative to the surrounding skin with a
roundish shape, present on the forehead, cheeks, and nose (Figure 1).
It subsequently calculates the percentage of skin area detected as
hyperpigmented spots. To test the image analysis accuracy, two
independent physicians manually graded the 100 photographs using
a 5-point photonumeric scale. There was a high correlation between
the average of the two manual grades and the values from the image
analysis (Spearman’s rho correlation coefﬁcient= 0.69; Hamer et al.,
2014). Furthermore, all 2,844 photos were visually controlled for
the type of hyperpigmentation, which should be solar lentigines or
seborrheic keratosis. Therefore, individuals with freckles (n= 23),
facial contusion (n= 1), facial scars with hyperpigmentation (n= 1),
and post inﬂammatory hyperpigmentation (n= 1) were excluded.
During the full-body skin examination, constitutional skin color was
assessed at sun-protected skin sites (trunk, upper legs; Green et al.,
1994). The skin color was graded into three levels: very white (9%),
white (78%), and white-to-olive (14%; Table 1).
In the LLS, severity of pigmented spots was manually graded using a
9-point photonumeric scale, taking area, intensity of color, and
uniformity of distribution into account (Grifﬁths et al., 1992). Grading
was performed independently by two skin aging experts using frontal
digital photographs, as described previously (Gunn et al., 2009, 2013).
Genotyping
In the RS, genotyping was carried out separately in the initial cohort
and the two extension cohorts using the Inﬁnium II HumanHap 550
and 660 K Genotyping BeadChip version 3 (Illumina, San Diego,
CA). Collection and puriﬁcation of DNA have been described
previously (Kayser et al., 2008). All genotyped SNPs (n= 537,405)
were imputed using the MACH software (http://csg.sph.umich.edu/
abecasis/MACH/index.html) (Li et al., 2010) based on the 1000G
Phase I Integrated Release Version 3 (released in March 2012)
reference panel (Genomes Project C, 2012) separately for the three
cohorts. Genotyping and quality control have been described in
detail previously (Lango Allen et al., 2010). After quality control, the
current study included a total of 6,846,125 autosomal SNPs
(MAF40.03, imputation Rsq40.3, SNP call rate40.97, HWE4
1× 10− 4) and 2,844 individuals (individual call rate40.95, pairwise
identity by descent sharing o0.25 (–genome option in PLINK),
excluding x-mismatches and outliers from MDS analysis). We
additionally conducted a GWAS using a more stringent identity by
descent sharing threshold (identity by descento0.1, n= 2,501). The
results are identical in terms of the loci showing signiﬁcant
association with pigmented spots and the effect sizes (Supple-
mentary Table S2, Supplementary Figure S3 online), which shows
that including individuals with an identity by descent sharingo0.25
does not affect the reliability of GWAS results.
The LLS offspring and partners were genotyped using Illumina
Inﬁnium HD Human660W-Quad BeadChips and Illumina OmniEx-
press and imputation was performed using IMPUTE with the 1000G
Phase I Integrated Release Version 3 (http://www.1000genomes.org/)
(released in March 2012) reference panel. Family relations and
imputation uncertainty were taken into account in the analysis by
specialized software, QT-assoc (Uh et al., 2012).
Statistical analysis
In the RS, the phenotype (area of pigmented spots) showed a highly
right-skewed distribution. We thus log transformed the phenotype,
resulting in an approximately normal distribution of both the
phenotype and the regression residuals. Because effect estimates
(regression betas) of log transformed outcome variables are not
directly interpretable, we represent all regression betas as the
percentage change (%Δ)––i.e., the percentage increase in the mean
value of the dependent variable (in our case pigmented spots
area) per unit increase in the independent variables (such as 1 year
of age or carrying one additional minor allele), calculated as
(exp (beta) – 1) * 100.
All analyses in the RS were adjusted for age, sex, the ﬁrst four
genetic principal components, and for variance between participants
LC Jacobs et al.
GWAS for Facial Pigmented Spots
1740 Journal of Investigative Dermatology (2015), Volume 135
in ﬂashlight illumination of the skin (Supplementary Methods online).
In the discovery GWAS (RS), association with autosomal SNPs was
tested using linear regression assuming an additive allele effect. The
inﬂation factor lambda was close to 1.0 (λ= 1.02) and not further
considered. A conditional GWAS, adjusted for the top SNP per locus,
was performed. We also conducted GWAS separately in men
(n= 1,323) and in women (n= 1,521). All GWAS analyses were
conducted using PLINK (Purcell et al., 2007).
A total of 167 SNPs in 3 loci with P-valueso5× 10−8 from the
GWAS in the RS, plus the top SNP (at BNC2) from the conditional
GWAS, were selected for replication analysis in the LLS. SNPs
selected for replication were analyzed using linear regression,
adjusting for age, sex, and familial relations using the software
package QT-assoc (Uh et al., 2012), which is based on a modiﬁed
version of the score test. P-valueso0.05 were considered as a
signiﬁcant replication.
The CHS ofMC1R was calculated on the basis of the haplotypes of
six known and independent skin color SNPs in MC1R (rs1805005,
rs2228479, rs1805007, rs1805008, rs885479, and rs1805009; Liu
et al., 2013), which were present in the RS. The haplotypes were
calculated with statistical software R (www.R-project.org), package
“haplo.stats”. To calculate the M1CR CHS, we added up the number
of variant type haplotypes per individual (Supplementary Table S3
online). A variant type haplotype carries at least one effect allele. The
CHS is therefore coded as 0, 1, or 2 and comparable to a SNP in
linear regression analysis.
Additional skin color-adjusted analyses were conducted in the RS.
A skin color-adjusted and a skin color-stratiﬁed analysis were
conducted for the top SNPs per locus in relation to pigmented spots.
Furthermore, known pigmentation genes were tested for association
with pigmented spots. Selection of the pigmentation genes was based
on signiﬁcant association with hair, eye, or skin color in previous
GWAS studies (Sulem et al., 2007; Han et al., 2008; Sulem et al.,
2008; Nan et al., 2009; Eriksson et al., 2010; Zhang et al., 2013) and
included the reported top-associated SNP at each of the gene loci,
MC1R, HERC2, OCA2, ASIP, TYR, TYRP1, IRF4, SLC45A2, SLC24A4,
TPCN2, KITLG, and BNC2, unless a different SNP was associated
with pigmented spots in this study. Association was tested in a
multivariable analysis, including these 12 pigmentation SNPs, age,
sex, and skin color (to test their independent effects, signiﬁcance
threshold Po0.005) and calculated the explained variance of
pigmented spots (r2). All statistical analyses were conducted using
statistical software R.
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